These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 26208431

  • 1. Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells.
    Munoz JL, Walker ND, Scotto KW, Rameshwar P.
    Cancer Lett; 2015 Oct 10; 367(1):69-75. PubMed ID: 26208431
    [Abstract] [Full Text] [Related]

  • 2. Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level.
    Munoz JL, Rodriguez-Cruz V, Ramkissoon SH, Ligon KL, Greco SJ, Rameshwar P.
    Oncotarget; 2015 Jan 20; 6(2):1190-201. PubMed ID: 25595896
    [Abstract] [Full Text] [Related]

  • 3. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
    Banelli B, Carra E, Barbieri F, Würth R, Parodi F, Pattarozzi A, Carosio R, Forlani A, Allemanni G, Marubbi D, Florio T, Daga A, Romani M.
    Cell Cycle; 2015 Jan 20; 14(21):3418-29. PubMed ID: 26566863
    [Abstract] [Full Text] [Related]

  • 4. Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.
    Le Calvé B, Rynkowski M, Le Mercier M, Bruyère C, Lonez C, Gras T, Haibe-Kains B, Bontempi G, Decaestecker C, Ruysschaert JM, Kiss R, Lefranc F.
    Neoplasia; 2010 Sep 20; 12(9):727-39. PubMed ID: 20824049
    [Abstract] [Full Text] [Related]

  • 5. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.
    Cheng Q, Ma X, Cao H, Chen Z, Wan X, Chen R, Peng R, Huang J, Jiang B.
    Mol Med Rep; 2017 Feb 20; 15(2):597-604. PubMed ID: 28035389
    [Abstract] [Full Text] [Related]

  • 6. Temozolomide induces the production of epidermal growth factor to regulate MDR1 expression in glioblastoma cells.
    Munoz JL, Rodriguez-Cruz V, Greco SJ, Nagula V, Scotto KW, Rameshwar P.
    Mol Cancer Ther; 2014 Oct 20; 13(10):2399-411. PubMed ID: 25053824
    [Abstract] [Full Text] [Related]

  • 7. Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide.
    Li H, Yuan X, Yan D, Li D, Guan F, Dong Y, Wang H, Liu X, Yang B.
    Cell Physiol Biochem; 2017 Oct 20; 42(3):1192-1201. PubMed ID: 28668966
    [Abstract] [Full Text] [Related]

  • 8. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W, Xu XK, Li JL, Kong KK, Li H, Chen C, He J, Wang F, Li P, Ge XS, Li FC.
    Oncotarget; 2017 Apr 04; 8(14):22783-22799. PubMed ID: 28187000
    [Abstract] [Full Text] [Related]

  • 9. Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide.
    Kan W, Gao L, Chen J, Chen L, Zhang G, Hao B, He M, Chen X, Wang C.
    Mol Neurobiol; 2024 Sep 04; 61(9):7066-7074. PubMed ID: 38368287
    [Abstract] [Full Text] [Related]

  • 10. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X, Wang M, Zuo J, Wahafu A, Mao P, Li R, Wu W, Xie W, Wang J.
    Life Sci; 2019 Nov 01; 236():116917. PubMed ID: 31614149
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
    Tian T, Mingyi M, Qiu X, Qiu Y.
    Oncotarget; 2016 Nov 29; 7(48):79584-79595. PubMed ID: 27792996
    [Abstract] [Full Text] [Related]

  • 12. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism.
    Lee CAA, Banerjee P, Wilson BJ, Wu S, Guo Q, Berg G, Karpova S, Mishra A, Lian JW, Tran J, Emmerich M, Murphy GF, Frank MH, Frank NY.
    J Biol Chem; 2020 May 29; 295(22):7774-7788. PubMed ID: 32317280
    [Abstract] [Full Text] [Related]

  • 13. EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.
    Hiddingh L, Tannous BA, Teng J, Tops B, Jeuken J, Hulleman E, Boots-Sprenger SH, Vandertop WP, Noske DP, Kaspers GJ, Wesseling P, Wurdinger T.
    Oncotarget; 2014 Jan 30; 5(2):363-74. PubMed ID: 24495907
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.
    Zhang N, Wu X, Yang L, Xiao F, Zhang H, Zhou A, Huang Z, Huang S.
    Clin Cancer Res; 2012 Nov 01; 18(21):5961-71. PubMed ID: 22977194
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.
    Wang N, Zhang Q, Ning B, Luo L, Fang Y.
    Biomed Pharmacother; 2017 Jun 01; 90():368-374. PubMed ID: 28380412
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.